Status:
RECRUITING
SwissGut - The Healthy Swiss Microbiome
Lead Sponsor:
Benjamin Misselwitz
Conditions:
Healthy
Eligibility:
All Genders
18-90 years
Brief Summary
Objective: This study is designed to address the complex interplay between the gut microbiome, environmental factors, and inflammatory diseases, with a specific emphasis on serving as a healthy cohor...
Detailed Description
Objective: This study investigates the relationship between lifestyle, gut bacteria, and diseases such as colorectal cancer and inflammatory bowel diseases (IBD). The investigators aim to understand ...
Eligibility Criteria
Inclusion
- Signed informed consent
- Age 18-90 years
- General ability to give consent for study inclusion, understand and follow study procedures
- No current or past diagnosis of IBD or colorectal carcinoma
- No current medical complaints typical for IBD or other severe intestinal diseases (e.g. Diarrhea, severe constipation, abdominal pain, blood in stool, weight loss). Minor symptoms, (not impairing daily activities) are permitted.
- No other current relevant gastrointestinal disease or condition plausibly interfering with microbiota assessment according to the discretion of the study physician.
Exclusion
- All patients with recent acute gastrointestinal disease (e.g., confirmed infectious diarrhea) within the last month or relevant intestinal symptoms (impairing daily activities).
- Use of antibiotics within the last 3 months.
- Current pouch or ileostomy/ colostomy.
- Severe medical, surgical, or psychiatric comorbidities interfering with study procedure according to the judgement of the investigator (patients with comorbidities that would not interfere with the primary endpoints I-III but don't allow the assessment of HRV according to the judgement of the investigator (e.g. heart diseases) will be included in the study but the HRV will not be assessed).
- Participation in an interfering clinical study.
Key Trial Info
Start Date :
May 28 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 5 2025
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06191224
Start Date
May 28 2023
End Date
July 5 2025
Last Update
January 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Visceral Surgery and Medicine, Inselspital, Bern University Hospital, University of Bern, Switzerland
Bern, Switzerland, 3010